Scarica l'app Stockscreener
1,123.00
0.11%
-1.21
Dopo l'orario di chiusura:
1123.06
0.06
+0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LLY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Lilly Eli Co Borsa (LLY) Ultime notizie
Lilly doubles down on women's health strategy - briefs.co
Why Eli Lilly (NYSE:LLY) Draws Notice As Metabolic-Disease Pipeline Advances - Kalkine Media
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH - The Motley Fool
Merck Stock Vs. LLY: Why Is The Slower Grower More Expensive? - Trefis
Got $10,000? Eli Lilly vs. Nvidia: The Better Buy For 2026 - 24/7 Wall St.
Eli Lilly Stock Has Become a Trillion-Dollar Giant. Is It Too Late to Buy? - 24/7 Wall St.
$Eli Lilly and Co (LLY.US)$ - Moomoo
Eli Lilly (NYSE:LLY): Is This Run Still Undervalued? - Kalkine Media
Lilly’s GLP-1 Windfall to Fund Push Into Women’s Health - Bloomberg.com
Lilly’s GLP-1 Windfall to Fund Investments in Women’s Health - The Business of Fashion
HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating - marketscreener.com
Why Is Eli Lilly (NYSE:LLY) Drawing Market Attention? - Kalkine Media
The Zacks Analyst Blog Highlights Eli Lilly, Palo Alto, Texas Instruments and Stratus Properties - Yahoo Finance
Calif. Judge Hands Eli Lilly Mixed Bag In Compound Drug Row - Law360
Top Analyst Reports for Eli Lilly, Palo Alto Networks & Texas Instruments - Yahoo Finance Singapore
Eli Lilly investing hundreds of thousands of dollars to bolster Kenosha manufacturing workforce - The Business Journals
Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks - Yahoo Finance
BMO reiterates Eli Lilly stock rating on incretin growth outlook - Investing.com
BMO reiterates Eli Lilly stock rating on incretin growth outlook By Investing.com - Investing.com UK
Prediction: This Is What a $5,000 Investment in Eli Lilly Will Be Worth in 2031 - The Motley Fool
What Is Shaping Interest in Eli Lilly Stock? (NYSE:LLY) - Kalkine Media
Eli Lilly 'Sabotaged' Rezpeg's Development, Nektar Tells Jury - Law360
Advanced Micro Devices Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks - investorplace.com
Eli Lilly lawsuit against weight-loss drug seller gets another shave - Courthouse News
Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 10 Years - Benzinga
Here's Why Eli Lilly (LLY) Fell More Than Broader Market - Yahoo Finance
Eli Lilly (NYSE:LLY) Heads Into Conference Season With A Broadening Pipeline - Kalkine Media
ELI LILLY Executive Vice President Eric Dozier Retains 14,239 Shares Following Gift Transaction - Kalkine Media
Eli Lilly scholarship backs Gateway manufacturing students - Kenosha News
Lilly fighting black market for its next obesity drug - theindianalawyer.com
Eli Lilly (NYSE:LLY): Can New FDA Approvals Fuel Growth? - Kalkine Media
Why Is Eli Lilly Stock Falling Tuesday? - Benzinga
Lilly invests SGD $42M in new Digital Health Hub in Singapore - Singapore Economic Development Board (EDB)
Radioligand Therapy Market to Grow from USD 2.98 Billion in 2025 to USD 15.85 Billion by 2035, at a CAGR of 18.2% - GlobeNewswire Inc.
Eli Lilly vs. Novo Nordisk: One Has 39% Upside. I'm Picking the Other. - Barchart.com
Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock? - Yahoo Finance
Eli Lilly and Company (LLY) Stock Analysis: Exploring a Potential 14.46% Upside in the Healthcare Giant - DirectorsTalk Interviews
Eli Lilly expands US pharmaceutical manufacturing with over US$50bn investment - Scientist Live
Eli Lilly’s $100B incretin opportunity: Is more upside coming? - Investing.com
Eli Lilly (LLY) Posts 52 Week Trial Data, Is The Stock Trading At A Discount? - simplywall.st
Prediction: Here's What a $5,000 Investment in Eli Lilly Could Look Like in 5 Years - The Motley Fool
Will Eli Lilly Split Its Stock? Here's What History Says Will Happen If It Does. - The Motley Fool
Atopic Dermatitis Drugs Market Set to Reach USD 33.42 Billion by 2035, at a CAGR of 7.70% - GlobeNewswire Inc.
Lilly (LLY) Down 2.7% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Lilly looks beyond obesity with $2.88B autoimmune buyout - thestreet.com
The Oral GLP-1 Tracker: Novo's Wegovy pill, Lilly's Foundayo grow scripts - Fierce Pharma
DRUGS AND BIOLOGICS—5th Cir.: Fifth Circuit upholds FDA's removal of tirzepatide from drug shortage list, rejecting compounders' APA challenges - VitalLaw.com
Eli Lilly and Company $LLY Shares Bought by BNP Paribas - insurancenewsnet.com
Eli Lilly Just Announced a Major Acquisition. Here's What It Means. - The Motley Fool
Eli Lilly’s Foundayo Launches in UK Amid Counterfeit Risks - healthcare-digital.com
Lilly to acquire Merida Biosciences for up to $2.875bn - Manufacturing Chemist
Lilly’s Merida Deal Shows the GLP-1 King Is Already Thinking Beyond Obesity - MarketBeat
JPMorgan reiterates Eli Lilly stock rating on incretin growth - Investing.com
Smart toilet, AI platform among tech in use at drugmaker Eli Lilly’s new S$42 million hub in Singapore - Singapore Economic Development Board (EDB)
This New Zepbound Study Could Be Great News for Eli Lilly Investors - The Motley Fool
Eli Lilly to Buy Immunology Biotech Merida Biosciences in $2.9B Deal - Yahoo Finance
Lilly to acquire biotechnology company for $2.8B - dailyjournal.net
Lilly’s dealmaking spreads the wealth among a broad set of biotech venture investors - Endpoints News
BMO reiterates Eli Lilly stock Outperform on Merida acquisition - Investing.com
Merida Biosciences Acquisition by Eli Lilly for Up to $2.875 Bil - GuruFocus
0.27%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):